Matches in Wikidata for { <http://www.wikidata.org/entity/Q96124395> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q96124395 description "artículu científicu espublizáu en xunu de 2020" @default.
- Q96124395 description "scientific article published on 01 June 2020" @default.
- Q96124395 description "wetenschappelijk artikel" @default.
- Q96124395 description "наукова стаття, опублікована 1 червня 2020" @default.
- Q96124395 name "Efficacy and safety of MT10107 (Coretox®) in post-stroke upper limb spasticity treatment: A randomized, double-blind, active drug-controlled, multi-center, phase III clinical trial" @default.
- Q96124395 name "Efficacy and safety of MT10107 (Coretox®) in post-stroke upper limb spasticity treatment: A randomized, double-blind, active drug-controlled, multi-center, phase III clinical trial" @default.
- Q96124395 type Item @default.
- Q96124395 label "Efficacy and safety of MT10107 (Coretox®) in post-stroke upper limb spasticity treatment: A randomized, double-blind, active drug-controlled, multi-center, phase III clinical trial" @default.
- Q96124395 label "Efficacy and safety of MT10107 (Coretox®) in post-stroke upper limb spasticity treatment: A randomized, double-blind, active drug-controlled, multi-center, phase III clinical trial" @default.
- Q96124395 prefLabel "Efficacy and safety of MT10107 (Coretox®) in post-stroke upper limb spasticity treatment: A randomized, double-blind, active drug-controlled, multi-center, phase III clinical trial" @default.
- Q96124395 prefLabel "Efficacy and safety of MT10107 (Coretox®) in post-stroke upper limb spasticity treatment: A randomized, double-blind, active drug-controlled, multi-center, phase III clinical trial" @default.
- Q96124395 P1433 Q96124395-4451EE93-03BF-481A-BF3F-FA837D21A9CC @default.
- Q96124395 P1476 Q96124395-C460CFC5-EA8B-43AB-9FD9-F68810A2DC36 @default.
- Q96124395 P2093 Q96124395-0D3FF6E7-2B1B-4426-8B63-56B6C2CD2DF1 @default.
- Q96124395 P2093 Q96124395-322C7548-5A4D-4E35-807B-DB8D1084051F @default.
- Q96124395 P2093 Q96124395-3841FBB7-A197-470C-89BA-32567E6CB513 @default.
- Q96124395 P2093 Q96124395-552775D1-92B0-432A-9600-E0CCDBBF2C5D @default.
- Q96124395 P2093 Q96124395-5B2388EA-2F70-47E1-8543-162DA6CA0AF7 @default.
- Q96124395 P2093 Q96124395-7595843A-A8A6-4280-B0DC-5CA66015C003 @default.
- Q96124395 P2093 Q96124395-B4967A15-40D8-446C-92D9-B36F39B9BF61 @default.
- Q96124395 P2093 Q96124395-E560FE43-CDC0-422F-9499-D929E6B03E00 @default.
- Q96124395 P31 Q96124395-2B176C7B-D748-44EF-B814-DDE13AE46CD3 @default.
- Q96124395 P356 Q96124395-A6F6592A-E2EE-42AD-94E5-9E3581DA3086 @default.
- Q96124395 P577 Q96124395-D3496315-53E6-446F-B405-441917AD5988 @default.
- Q96124395 P698 Q96124395-565E69A0-2C80-4504-96FB-3CD8FD6C62E4 @default.
- Q96124395 P921 Q96124395-911D7CD7-F990-4C39-8BF0-5B6E2F47B5A7 @default.
- Q96124395 P921 Q96124395-AE6F94CE-B8F0-48F2-909A-0DDC59A852E8 @default.
- Q96124395 P356 J.APMR.2020.03.025 @default.
- Q96124395 P698 32497599 @default.
- Q96124395 P1433 Q4787307 @default.
- Q96124395 P1476 "Efficacy and safety of MT10107 (Coretox®) in post-stroke upper limb spasticity treatment: A randomized, double-blind, active drug-controlled, multi-center, phase III clinical trial" @default.
- Q96124395 P2093 "Bum Sun Kwon" @default.
- Q96124395 P2093 "Deog Young Kim" @default.
- Q96124395 P2093 "Junekyung Lee" @default.
- Q96124395 P2093 "Min Ho Chun" @default.
- Q96124395 P2093 "Nam-Jong Paik" @default.
- Q96124395 P2093 "Shi-Uk Lee" @default.
- Q96124395 P2093 "Yoon Ghil Park" @default.
- Q96124395 P2093 "Young Jin Ko" @default.
- Q96124395 P31 Q13442814 @default.
- Q96124395 P356 "10.1016/J.APMR.2020.03.025" @default.
- Q96124395 P577 "2020-06-01T00:00:00Z" @default.
- Q96124395 P698 "32497599" @default.
- Q96124395 P921 Q117060 @default.
- Q96124395 P921 Q42824827 @default.